What stage does Cross-Border Impact Ventures invest at?

Cross-Border Impact Ventures invests at the Series A, Series B stages.

What is Cross-Border Impact Ventures's typical check size?

Cross-Border Impact Ventures typically writes checks of $2M – $10M.

Where is Cross-Border Impact Ventures located?

Cross-Border Impact Ventures is headquartered in Toronto, CA.

Cross-Border Impact Ventures

Impact investor

Toronto · Series A–Series B · 12 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

The firm invests in companies commercializing globally relevant medical devices, diagnostics, therapeutics and digital health innovations that address market opportunities in women, children and adolescent health. It focuses on four areas: sexual and reproductive health; maternal, newborn and child health; general health including chronic diseases; and health software infrastructure. Applying a gender and diversity lens, it targets companies addressing gender health inequalities and pursues both positive impact and financial returns. As hands-on investors, the firm supports management teams with access to new markets, unique forms of capital and health technology expertise across North America, Europe and global markets.

Invests inAI & Machine Learning Biotech Digital Health FemTech Healthtech Impact & Social Good Medical Devices SaaSAfricaCanadaEuropeGlobalIsraelNorth AmericaTorontoUnited States

Source: firm website, verified Aug 11, 2026.

Stage

Series A–Series B

Check

$2M – $10M

Toronto, Ontario, CA

Instruments

Equity

Founded

2019

AUM

$120M

VC funds

Tracked investments

Team · 12 people

from the firm's website & public directories

Annie Thériault· Managing Partner· Canadain

Managing Partner focused on inclusive health technology investing with a gender and impact lens; previously Chief Investment Officer at Grand Challenges Canada. Holds a PhD in Management from the University of Toronto, is a CFA Charterholder and holds the ICD.D designation.

Annie Theriault· Managing Partner

Managing Partner of Cross-Border Impact Ventures, featured in a Pulse 2.0 interview about the firm's mission to invest in transformative health technology companies serving women, children and adolescents.

a•••@crossborder.venturesreveal

Donna Parr· Managing Partner· Canadain

Managing Partner with over 30 years managing venture capital, growth equity and private debt portfolios of up to $1 billion, including two biotech funds and roles at pension funds OMERS and CPP. Holds an MBA from Schulich and the ICD.D designation.

d•••@crossborder.venturesreveal

Megan Dover· Partnerin

Partner and co-founder with experience in impact and angel investing, venture advisory and M&A; previously mobilized $46 million in equity and non-dilutive capital for a health technology portfolio. Holds an MBA from the University of Toronto and an engineering degree from Queen's University.

m•••@crossborder.venturesreveal

Issy Gordon· Investment Director· London, England, United Kingdomin

Investment Director who spent five years on the early-stage investment team at Salica Investments (formerly Hambro Perks), leading healthcare investment strategy. Holds a Master's in Management from London Business School.

Cyriac Alappat· Principal

c•••@crossborder.venturesreveal

Pooja Sikka· Venture Partner· London, England, United Kingdomin

Venture Partner and practising medical doctor with over 20 years in health and life sciences; former Partner at Octopus Ventures and former head of EY UK's healthcare corporate venture portfolio, having invested over $60m in early-stage companies. Holds an MBA from Imperial College London and an MBBS.

Femke Smeets· Managing Director of Emerging Markets· Hilversum, North Holland, Netherlandsin

Health impact leader with nearly 20 years in business development, health financing and impact management across Africa, Latin America, the US and Europe. Holds a Master's in International Relations from the University of Amsterdam.

Hannah Sharpe· ESG and Health Impact Associate· Toronto, Ontario, Canadain

ESG and Health Impact Associate with seven years at the intersection of environment and health, previously a sustainability consultant and life science lead at a pre-seed health-tech company. Holds a Master's in Environment and Sustainability from Western University.

Juanita Cortés· Chief Financial Officerin

CFO with financial leadership experience across private and public sectors, supporting companies through IPOs and M&A. Qualified as a Public Accountant and Auditor in Mexico with over 25 years of Canadian experience.

Tasha Noronha· Partnerships & Operations Manager· Canadain

Partnerships and Operations Manager with a decade in project management and stakeholder engagement across real estate and global health, previously at the Grand Challenges Canada Foundation. Holds a Bachelor's in International Development Studies from the University of Toronto.

Hamza Kayani· Investment Analyst

h•••@crossborder.venturesreveal

What they invest in

from 2 of 9 portfolio companies

AI & Machine Learning ×1Digital Health ×1Healthtech ×1Medical Devices ×1

HQs:United States×2

Investments · 9 tracked

founders shown can be your intro path

Axena Health

HealthtechAuburndale, US

Samantha Pulliam(Executive Officer, Director)Vincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)Shacey Petrovic(Executive Officer, Director)Eileen Maus(Executive Officer, Director)

BoardJonathan Dean(Director)

Cardiosensecardiosense.comin 𝕏Nov 2022

Cardiosense develops the CardioTag, a noninvasive point-of-care cardiac monitoring device that measures pulmonary capillary wedge pressure to enable early detection and management of worsening heart failure across emergency, inpatient, and outpatient settings.

AI & Machine LearningDigital HealthMedical DevicesChicago, US

Omer Tolga Inan(Director)Amit K. Gupta(Executive Officer, Director)Andrew Michael Carek(Executive Officer)

BoardJeff Terrell(Director)Daniel Gottlieb(Director)

Daye

Femtech gynecological health platform offering period care products, a pelvic pain clinic, and tampon-based diagnostic testing.

mOm Incubators

Medical device company making the mOm Essential Incubator, a low-cost, collapsible, regulatory-approved infant incubator.

OncoLensoncolens.comin 𝕏

Oxford Cancer Analytics

Biomarker discovery platform (OXcan) using proteomics and machine learning for affordable liquid-biopsy cancer detection.

Pendulum

Health infrastructure software using AI/ML to forecast healthcare demand and reduce supply chain wastage and stockouts.

Raydiant Oxymetryraydiantoximetry.comin

Building the family planning company of the 21st century with novel non-hormonal contraceptives for men and women.

Soniosonio.ai

AI empowering practitioners during prenatal ultrasound scans to secure screening and optimize diagnosis.

Frequently asked questions

What stage does Cross-Border Impact Ventures invest at?: Cross-Border Impact Ventures invests at the Series A, Series B stages.
What is Cross-Border Impact Ventures's typical check size?: Cross-Border Impact Ventures typically writes checks of $2M – $10M.
What sectors does Cross-Border Impact Ventures focus on?: Cross-Border Impact Ventures focuses on AI & Machine Learning, Biotech, Digital Health, FemTech, Healthtech, Impact & Social Good, Medical Devices, SaaS.
Where is Cross-Border Impact Ventures located?: Cross-Border Impact Ventures is headquartered in Toronto, CA.

Similar investors

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.

$250K

Foreground Capital

Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.

Portfolia

Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.

WELL Ventures

WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.

Innovestor Ventures

Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.

$270K – $3.2M